Full Text
Full Text PDF
Abstract
Hepatitis C virus (HCV) infection is an important comorbidity factor during several stages of chronic kidney disease. There is no consensus in the literature about the diagnosis, evaluation and treatment of HCV infection in chronic kidney disease. KDIGO (Kidney Disease-Improving Global Outcomes), whose major mission is to prepare global guidelines, has prepared its first guideline on this issue. In this commentary, the major clauses of KDIGO-HCV guideline is reviewed and has been compared with our national policies in order to get a better local use of the guideline.
Similar Articles
Article Info
Published In
Journal
Turkish Journal of Nephrology
Volume / Issue
Volume 17 · Issue 3
Pages
89-91
History
Published Online
February 13, 2019
Copyright
Copyright (c) 2008 Turkish Journal of Nephrology
Affiliations
Serhan V. PİŞKİNPAŞA
Hacettepe Üniversitesi Tıp Fakültesi, İç Hastalıkları AD, Nefroloji Ünitesi, Ankara
Mustafa ARICI
Hacettepe Üniversitesi Tıp Fakültesi, İç Hastalıkları AD, Nefroloji Ünitesi, Ankara
Cite this Article
PİŞKİNPAŞA, S. V., & ARICI, M. (2019). KDIGO Clinical Practice Guidelines for the Prevention, Diagnosis, Evaluation and Treatment of Hepatitis C in Chronic Kidney Disease. Turkish Journal of Nephrology, 17(3), 89–91. Retrieved from https://www.turkjnephrol.org/index.php/pub/article/view/634
Outlines